Maria Alexandrovna Makarova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Alexandrovna Makarova has a total of 237 co-authors. Here are the top co-authors by number of shared publications:
- Lidia Alekseevna Kaftyreva
Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia
20 shared publications - Zoya N. Matveeva
Saint-Petersburg Pasteur Institute, 197101, Saint-Petersburg, Russia
7 shared publications - Lyudmila V. Suzhaeva
Laboratory of Identification of the Pathogens, St. Petersburg Pasteur Institute, 197101 St. Petersburg, Russia
6 shared publications - Svetlana Alexandrovna Egorova
Laboratory of Identification of the Pathogens, St. Petersburg Pasteur Institute, St. Petersburg, Russia
6 shared publications - Elena V. Voitenkova
ФБУН НИИ эпидемиологии и микробиологии имени Пастера
3 shared publications - François-Xavier Weill
Institut Pasteur, Université Paris Cité, Unité des Bactéries Pathogènes Entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, France
3 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Alfmed LLC in Medical alphabet
- No. 14,p. 48-53
Comparative analysis of acute intestinal infections of polymicrobial etiology identified in children's and adult infectious diseases hospitals
Comparative analysis of acute intestinal infections of polymicrobial etiology identified in children's and adult infectious diseases hospitals | Bogdanova | Medical alphabet Сравнительный анализ острых кишечных инфекций полимикробной этиологии, выявленных в детской и взрослой инфекционных больницах | Богданова | Медицинский алфавит
- 22 July 2026
- Published by Alfmed LLC in Medical alphabet
- No. 14,p. 48-53
Open AccessComparative analysis of acute intestinal infections of polymicrobial etiology identified in children's and adult infectious diseases hospitals
Comparative analysis of acute intestinal infections of polymicrobial etiology identified in children's and adult infectious diseases hospitals | Bogdanova | Medical alphabet Сравнительный анализ острых кишечных инфекций полимикробной этиологии, выявленных в детской и взрослой инфекционных больницах | Богданова | Медицинский алфавит
- Open Access
- 30 April 2026
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (2) , 216-228
Molecular epidemiology of the nosocomial Salmonella Typhimurium ST328 clone based on whole-genome sequencing data
Background. Salmonella enterica serovar Typhimurium remains one of the leading causes of acute bacterial gastroenteritis worldwide. The emergence and dissemination of high-risk clones with multidrug resistance and capacity for prolonged nosocomial circulation represents a serious public health threat. Objective: Based on genomic data, to characterize S. Typhimurium ST328 isolates, including the determination of its population structure, phylogeography, and mechanisms of antimicrobial resistance in the context of the global S. Typhimurium population. Materials and methods. Eleven S. Typhimurium isolates were recovered from children with nosocomial salmonellosis in Gomel, Belarus, in 2002. Minimum inhibitory concentrations (MICs) were determined by broth microdilution method. Extended-spectrum β-lactamase (ESBL) production was detected using the double-disk method. Whole-genome sequencing was performed on the Illumina MiSeq platform. Bioinformatic analysis included serogenotyping (SISTR), multilocus sequence typing (MLST), ribosomal MLST (rMLST), identification of resistance genes (ResFinder 4.1), and phylogenetic single-nucleotide polymorphism (SNP) analysis using the EnteroBase database. Results. A total of 81.8% of isolates belonged to sequence type ST328 and ribosomal type rST60463. Phenotypically, 72.7% of strains exhibited resistance to third-generation cephalosporins, and 63.6% produced ESBL. The blaCTX-M-5 gene was detected in 77.8% of ST328 strains, which completely correlated with the phenotype. Phylogenetic analysis of 112 ST328 strains from 10 countries revealed two subgroups (rST1344 and rST60463), differing in geographic distribution and resistance profiles. Screening of 713,000 Salmonella genomes in EnteroBase confirmed that blaCTX-M-5 was associated exclusively with the ST328/rST60463 lineage. Conclusions. The S. Typhimurium ST328/rST60463 clone, producing ESBL CTX-M-5, circulated in Belarus in 2002 and represents a high-risk epidemiological clone. The results underscore the importance of enhanced genomic surveillance of nosocomial pathogens using international databases.
- 30 April 2026
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (2) , 216-228
Open AccessMolecular epidemiology of the nosocomial Salmonella Typhimurium ST328 clone based on whole-genome sequencing data
Background. Salmonella enterica serovar Typhimurium remains one of the leading causes of acute bacterial gastroenteritis worldwide. The emergence and dissemination of high-risk clones with multidrug resistance and capacity for prolonged nosocomial circulation represents a serious public health threat. Objective: Based on genomic data, to characterize S. Typhimurium ST328 isolates, including the determination of its population structure, phylogeography, and mechanisms of antimicrobial resistance in the context of the global S. Typhimurium population. Materials and methods. Eleven S. Typhimurium isolates were recovered from children with nosocomial salmonellosis in Gomel, Belarus, in 2002. Minimum inhibitory concentrations (MICs) were determined by broth microdilution method. Extended-spectrum β-lactamase (ESBL) production was detected using the double-disk method. Whole-genome sequencing was performed on the Illumina MiSeq platform. Bioinformatic analysis included serogenotyping (SISTR), multilocus sequence typing (MLST), ribosomal MLST (rMLST), identification of resistance genes (ResFinder 4.1), and phylogenetic single-nucleotide polymorphism (SNP) analysis using the EnteroBase database. Results. A total of 81.8% of isolates belonged to sequence type ST328 and ribosomal type rST60463. Phenotypically, 72.7% of strains exhibited resistance to third-generation cephalosporins, and 63.6% produced ESBL. The blaCTX-M-5 gene was detected in 77.8% of ST328 strains, which completely correlated with the phenotype. Phylogenetic analysis of 112 ST328 strains from 10 countries revealed two subgroups (rST1344 and rST60463), differing in geographic distribution and resistance profiles. Screening of 713,000 Salmonella genomes in EnteroBase confirmed that blaCTX-M-5 was associated exclusively with the ST328/rST60463 lineage. Conclusions. The S. Typhimurium ST328/rST60463 clone, producing ESBL CTX-M-5, circulated in Belarus in 2002 and represents a high-risk epidemiological clone. The results underscore the importance of enhanced genomic surveillance of nosocomial pathogens using international databases.
- Open Access
- 28 December 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (6) , 702-718
The efficacy of bacteriophages in destroying biofilms on urinary catheters in experimental in vitro and in vivo models
Introduction. The formation of biofilms by healthcare-associated infection (HAI) pathogens on invasive medical devices is an increasingly urgent problem in clinical practice. Microbial biofilms contribute to persistent infections, complicate treatment, increase healthcare costs, and reduce the quality of patient care. The resistance of biofilm-embedded bacteria to antibiotics is a key factor in chronic and recurrent infections. In this context, bacteriophages may serve as a promising therapeutic agent against bacterial infections, including those caused by biofilm-forming microorganisms. Objective. To assess the efficacy of lytic bacteriophages in disrupting microbial biofilms on urinary catheters using in vitro and in vivo experimental models. Materials and methods. The study employed microbiological, morphological, and electron microscopy techniques. In vitro, biofilms were cultured on urinary catheter surfaces and subsequently treated with bacteriophages. For the in vivo model, catheter-associated urinary tract infection (CAUTI) was induced in mice, which were then divided into experimental and control groups. Bacteriophages were administered transurethrally. Results. In the in vitro model, bacteriophages effectively disrupted biofilms, inducing bacterial cell lysis and degradation of the exopolysaccharide matrix. In the in vivo experiments, mice treated with bacteriophages exhibited regression of CAUTI, as confirmed by morphological and bacteriological analyses. Electron microscopy revealed biofilm destruction on 5 out of 6 catheters. In contrast, the positive control group showed progressive infection, while no biofilm formation was observed in the negative controls. Conclusions. The findings from both in vitro and in vivo experiments demonstrate that bacteriophages are capable of degrading biofilms and may represent an effective therapeutic strategy against biofilm-associated HAIs.
- 28 December 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (6) , 702-718
Open AccessThe efficacy of bacteriophages in destroying biofilms on urinary catheters in experimental in vitro and in vivo models
Introduction. The formation of biofilms by healthcare-associated infection (HAI) pathogens on invasive medical devices is an increasingly urgent problem in clinical practice. Microbial biofilms contribute to persistent infections, complicate treatment, increase healthcare costs, and reduce the quality of patient care. The resistance of biofilm-embedded bacteria to antibiotics is a key factor in chronic and recurrent infections. In this context, bacteriophages may serve as a promising therapeutic agent against bacterial infections, including those caused by biofilm-forming microorganisms. Objective. To assess the efficacy of lytic bacteriophages in disrupting microbial biofilms on urinary catheters using in vitro and in vivo experimental models. Materials and methods. The study employed microbiological, morphological, and electron microscopy techniques. In vitro, biofilms were cultured on urinary catheter surfaces and subsequently treated with bacteriophages. For the in vivo model, catheter-associated urinary tract infection (CAUTI) was induced in mice, which were then divided into experimental and control groups. Bacteriophages were administered transurethrally. Results. In the in vitro model, bacteriophages effectively disrupted biofilms, inducing bacterial cell lysis and degradation of the exopolysaccharide matrix. In the in vivo experiments, mice treated with bacteriophages exhibited regression of CAUTI, as confirmed by morphological and bacteriological analyses. Electron microscopy revealed biofilm destruction on 5 out of 6 catheters. In contrast, the positive control group showed progressive infection, while no biofilm formation was observed in the negative controls. Conclusions. The findings from both in vitro and in vivo experiments demonstrate that bacteriophages are capable of degrading biofilms and may represent an effective therapeutic strategy against biofilm-associated HAIs.
- Open Access
- 31 October 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (5) , 635-646
Next-generation protective gloves: current trends in technological solutions and application prospects (scientific review)
Introduction. Protective gloves are widely used in medicine to provide biological protection for patients and medical staff. However, if gloves are used improperly, there is a risk of healthcare-associated infections (HAIs) for both staff and patients. A significant problem is the resulting growth in medical waste and its disposal. Therefore, developing new approaches to ensure maximum protection for staff and patients, and minimize the risk of infection, by creating protective gloves based on biodegradable polymer materials with an antimicrobial coating, is an urgent epidemiological and environmental objective. This paper discusses modern technologies and emerging issues in the creation of new materials for protective gloves with antimicrobial properties. These materials can be made using guanidine derivatives, quaternary ammonium compounds (QACs), chlorinated phenols, essential oils, iodine compounds, silver salts, metal oxides and metal nanoparticles and oxides, vegetable oil extracts, aniline dyes. The introduction of biofillers such as starch and nanocellulose will help improve biodegradability. They will also help maintain the necessary physical and chemical characteristics. The problem of synthetic rubber waste disposal can be solved by the development of new composite materials with improved biodegradation characteristics. These materials are in the form of thermoplastic elastomers (TPE), polylactide (PLA) and polylactone (PLC). Conclusion. A review of the scientific literature revealed a significant global interest in the creation of protective gloves with antimicrobial properties made from biodegradable materials. However, in addition to directly suppressing the growth of pathogenic microflora, their use may also pose a number of problems related to their impact on human health and the ecosystem. The successful implementation of this direction hinges on the continuation of scientific research on imparting the declared properties to gloves. This research should use effective, reliable and safe technologies, as well as the development of unified methods and protocols for assessing antimicrobial activity. Once these are in place, the research can be implemented widely in practice. The production of biodegradable protective gloves offers significant potential, as it will help to reduce the risk of infection spreading in healthcare organizations and contribute to environmental protection.
- 31 October 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (5) , 635-646
Open AccessNext-generation protective gloves: current trends in technological solutions and application prospects (scientific review)
Introduction. Protective gloves are widely used in medicine to provide biological protection for patients and medical staff. However, if gloves are used improperly, there is a risk of healthcare-associated infections (HAIs) for both staff and patients. A significant problem is the resulting growth in medical waste and its disposal. Therefore, developing new approaches to ensure maximum protection for staff and patients, and minimize the risk of infection, by creating protective gloves based on biodegradable polymer materials with an antimicrobial coating, is an urgent epidemiological and environmental objective. This paper discusses modern technologies and emerging issues in the creation of new materials for protective gloves with antimicrobial properties. These materials can be made using guanidine derivatives, quaternary ammonium compounds (QACs), chlorinated phenols, essential oils, iodine compounds, silver salts, metal oxides and metal nanoparticles and oxides, vegetable oil extracts, aniline dyes. The introduction of biofillers such as starch and nanocellulose will help improve biodegradability. They will also help maintain the necessary physical and chemical characteristics. The problem of synthetic rubber waste disposal can be solved by the development of new composite materials with improved biodegradation characteristics. These materials are in the form of thermoplastic elastomers (TPE), polylactide (PLA) and polylactone (PLC). Conclusion. A review of the scientific literature revealed a significant global interest in the creation of protective gloves with antimicrobial properties made from biodegradable materials. However, in addition to directly suppressing the growth of pathogenic microflora, their use may also pose a number of problems related to their impact on human health and the ecosystem. The successful implementation of this direction hinges on the continuation of scientific research on imparting the declared properties to gloves. This research should use effective, reliable and safe technologies, as well as the development of unified methods and protocols for assessing antimicrobial activity. Once these are in place, the research can be implemented widely in practice. The production of biodegradable protective gloves offers significant potential, as it will help to reduce the risk of infection spreading in healthcare organizations and contribute to environmental protection.
- Open Access
- 15 September 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (4) , 436-444
Etiological structure of acute intestinal infections based on the results of exterritorial monitoring
Introduction. Acute intestinal infections cause high morbidity and mortality, especially in Africa and Southeast Asia, where millions of children under the age of five die every year. The Republic of Guinea urgently requires large-scale research aimed at studying the causes of diarrheal diseases, necessary for the development of effective preventive measures to ensure the preservation of the health of its population. Aim. To conduct a analysis of the etiological structure of acute intestinal infections in the Republic of Guinea. Materials and methods. Stool samples (n = 724) from residents of the Republic of Guinea with diarrheal syndrome were studied by real-time PCR with two reagent kits: 1) AmpliSens OKI screen-FL for the detection of DNA (RNA) of microorganisms Shigella spp./EIEC, Salmonella spp., Campylobacter spp., Adenovirus, Rotavirus, Norovirus and Astrovirus; 2) AmpliSens Escherichiosis-FL for the detection of DNA of diarrheagenic Escherichia coli (DEC) of five pathogroups: EPEC, EHEC, ETEC, EIEC, EAgEC. Results. In the period 2019-2022, 66.2% of the examined children and adults revealed the presence of genetic markers of acute intestinal infections, mainly of bacterial etiology (74.1%), among which diarrheagenic E. coli dominated (62.4%). Genetic markers of viral pathogens were detected significantly less frequently by 25.9%, p 0.05. Young children are most vulnerable to infection caused by E. coli. Bacterial pathogens dominate both in cases of monoinfections and in cases of mixed infection with two or more types of pathogens. Conclusion. A study has shown that DEC is the main cause of intestinal infections in Guinea. The data obtained will become the basis for the development of an effective program for the prevention and treatment of acute intestinal infections in the republic.
- 15 September 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (4) , 436-444
Open AccessEtiological structure of acute intestinal infections based on the results of exterritorial monitoring
Introduction. Acute intestinal infections cause high morbidity and mortality, especially in Africa and Southeast Asia, where millions of children under the age of five die every year. The Republic of Guinea urgently requires large-scale research aimed at studying the causes of diarrheal diseases, necessary for the development of effective preventive measures to ensure the preservation of the health of its population. Aim. To conduct a analysis of the etiological structure of acute intestinal infections in the Republic of Guinea. Materials and methods. Stool samples (n = 724) from residents of the Republic of Guinea with diarrheal syndrome were studied by real-time PCR with two reagent kits: 1) AmpliSens OKI screen-FL for the detection of DNA (RNA) of microorganisms Shigella spp./EIEC, Salmonella spp., Campylobacter spp., Adenovirus, Rotavirus, Norovirus and Astrovirus; 2) AmpliSens Escherichiosis-FL for the detection of DNA of diarrheagenic Escherichia coli (DEC) of five pathogroups: EPEC, EHEC, ETEC, EIEC, EAgEC. Results. In the period 2019-2022, 66.2% of the examined children and adults revealed the presence of genetic markers of acute intestinal infections, mainly of bacterial etiology (74.1%), among which diarrheagenic E. coli dominated (62.4%). Genetic markers of viral pathogens were detected significantly less frequently by 25.9%, p 0.05. Young children are most vulnerable to infection caused by E. coli. Bacterial pathogens dominate both in cases of monoinfections and in cases of mixed infection with two or more types of pathogens. Conclusion. A study has shown that DEC is the main cause of intestinal infections in Guinea. The data obtained will become the basis for the development of an effective program for the prevention and treatment of acute intestinal infections in the republic.
- Open Access
- 14 December 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (6) , 758-768
Pathogenic potential of ornithogenic Escherichia coli strains detected in the Earth's polar regions
Introduction. Pathogenic strains of Escherichia coli are an important object of surveillance within the One Health concept in the wild, agriculture and human society. Migratory bird colonies and high latitude avian colonies may be points of active intraspecies and interspecies contact between different animal species, accompanied by the spread of pathogens. At the same time, the phylogeography of E. coli in relation to the presence of natural foci of colibacillosis in polar regions remains virtually unstudied. The aim of this study was to assess the pathogenic potential of E. coli strains from the polar regions of the Earth, based on the analysis of the genomes of these bacteria from typical ornithogenic ecosystems of the Arctic and Antarctic. Materials and methods. The study used collections of E. coli isolated from ornithogenic biological material during expeditions to high latitude areas of the Arctic (archipelagos of Novaya Zemlya, Franz Josef Land, Svalbard) and Antarctic (Haswell Archipelago). 16 cultures associated with avian E. coli (12 polar and 4 temperate strains) were selected for genome-wide sequencing using BGI technology. The annotation of the genomes focused on the identification of genes for pathogenicity factors and antimicrobial resistance, as well as the identification of strains belonging to individual genetic lineages using the cgMLST method. Results. The annotation of the genomes allowed their assignment to different sequence types in the multilocus sequencing typing and genome-wide sequencing typing schemes. The analysis of the geographical distribution of the sequence types of polar E. coli strains determined by the cgMLST method showed their global representation in geographically distant regions of the planet. For example, cgST 133718 was observed in Antarctica (strain 17_1myr) and in the UK, and sequence 11903, to which strain 32-1 from the northernmost point of Novaya Zemlya belonged, was previously identified in the USA. All strains studied were characterized by the presence of extensive virulence. Among the pathogenicity factors identified were haemolysins A, E, F, siderophores, including the yersiniabactin gene cluster, a number of adhesion, colonization and invasion factors, as well as the thermostable enterotoxin EAST-1 and genes that characterize enteroaggregative strains of E. coli (the virulence regulator gene eilA and enteroaggregative protein (air)). One of the Arctic strains (33-1) had determinants of antibiotic resistance, in particular the extended-spectrum beta-lactamase gene TEM-1b and the Tn1721 transposon, including tetracycline resistance genes (tetA-TetR), were detected in its genome. Conclusion. The results of the study indicate the circulation of E. coli strains with strong pathogenic potential in high-latitude Arctic and Antarctic ornithogenic ecosystems. The analysis of genomic data indicates the presence of geographically widespread genetic lineages in these regions, which justifies the importance of monitoring epidemic clones of E. coli, along with monitoring for other pathogens, in bird colonies in high-latitude areas.
- 14 December 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (6) , 758-768
Open AccessPathogenic potential of ornithogenic Escherichia coli strains detected in the Earth's polar regions
Introduction. Pathogenic strains of Escherichia coli are an important object of surveillance within the One Health concept in the wild, agriculture and human society. Migratory bird colonies and high latitude avian colonies may be points of active intraspecies and interspecies contact between different animal species, accompanied by the spread of pathogens. At the same time, the phylogeography of E. coli in relation to the presence of natural foci of colibacillosis in polar regions remains virtually unstudied. The aim of this study was to assess the pathogenic potential of E. coli strains from the polar regions of the Earth, based on the analysis of the genomes of these bacteria from typical ornithogenic ecosystems of the Arctic and Antarctic. Materials and methods. The study used collections of E. coli isolated from ornithogenic biological material during expeditions to high latitude areas of the Arctic (archipelagos of Novaya Zemlya, Franz Josef Land, Svalbard) and Antarctic (Haswell Archipelago). 16 cultures associated with avian E. coli (12 polar and 4 temperate strains) were selected for genome-wide sequencing using BGI technology. The annotation of the genomes focused on the identification of genes for pathogenicity factors and antimicrobial resistance, as well as the identification of strains belonging to individual genetic lineages using the cgMLST method. Results. The annotation of the genomes allowed their assignment to different sequence types in the multilocus sequencing typing and genome-wide sequencing typing schemes. The analysis of the geographical distribution of the sequence types of polar E. coli strains determined by the cgMLST method showed their global representation in geographically distant regions of the planet. For example, cgST 133718 was observed in Antarctica (strain 17_1myr) and in the UK, and sequence 11903, to which strain 32-1 from the northernmost point of Novaya Zemlya belonged, was previously identified in the USA. All strains studied were characterized by the presence of extensive virulence. Among the pathogenicity factors identified were haemolysins A, E, F, siderophores, including the yersiniabactin gene cluster, a number of adhesion, colonization and invasion factors, as well as the thermostable enterotoxin EAST-1 and genes that characterize enteroaggregative strains of E. coli (the virulence regulator gene eilA and enteroaggregative protein (air)). One of the Arctic strains (33-1) had determinants of antibiotic resistance, in particular the extended-spectrum beta-lactamase gene TEM-1b and the Tn1721 transposon, including tetracycline resistance genes (tetA-TetR), were detected in its genome. Conclusion. The results of the study indicate the circulation of E. coli strains with strong pathogenic potential in high-latitude Arctic and Antarctic ornithogenic ecosystems. The analysis of genomic data indicates the presence of geographically widespread genetic lineages in these regions, which justifies the importance of monitoring epidemic clones of E. coli, along with monitoring for other pathogens, in bird colonies in high-latitude areas.
- Open Access
- 10 December 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Genomic perspective on the bacillus causing paratyphoid B fever
Paratyphoid B fever (PTB) is caused by an invasive lineage (phylogroup 1, PG1) of Salmonella enterica serotype Paratyphi B (SPB). However, little was known about the global population structure, geographic distribution, and evolution of this pathogen. Here, we report a whole-genome analysis of 568 historical and contemporary SPB PG1 isolates, obtained globally, between 1898 and 2021. We show that this pathogen existed in the 13th century, subsequently diversifying into 11 lineages and 38 genotypes with strong phylogeographic patterns. Following its discovery in 1896, it circulated across Europe until the 1970s, after which it was mostly reimported into Europe from South America, the Middle East, South Asia, and North Africa. Antimicrobial resistance recently emerged in various genotypes of SPB PG1, mostly through mutations of the quinolone-resistance-determining regions of gyrA and gyrB. This study provides an unprecedented insight into SPB PG1 and essential genomic tools for identifying and tracking this pathogen, thereby facilitating the global genomic surveillance of PTB.
- 10 December 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessGenomic perspective on the bacillus causing paratyphoid B fever
Paratyphoid B fever (PTB) is caused by an invasive lineage (phylogroup 1, PG1) of Salmonella enterica serotype Paratyphi B (SPB). However, little was known about the global population structure, geographic distribution, and evolution of this pathogen. Here, we report a whole-genome analysis of 568 historical and contemporary SPB PG1 isolates, obtained globally, between 1898 and 2021. We show that this pathogen existed in the 13th century, subsequently diversifying into 11 lineages and 38 genotypes with strong phylogeographic patterns. Following its discovery in 1896, it circulated across Europe until the 1970s, after which it was mostly reimported into Europe from South America, the Middle East, South Asia, and North Africa. Antimicrobial resistance recently emerged in various genotypes of SPB PG1, mostly through mutations of the quinolone-resistance-determining regions of gyrA and gyrB. This study provides an unprecedented insight into SPB PG1 and essential genomic tools for identifying and tracking this pathogen, thereby facilitating the global genomic surveillance of PTB.
- Open Access
- 16 July 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (3) , 315-326
Campylobacteriosis: genotypic characteristics of the pathogen and immunological status of patients
Introduction. Campylobacteriosis is among the leading causes of acute gastrointestinal infections. The severity of campylobacteriosis and the development of long-term complications may be influenced by the genotype of the pathogen, whose biological properties can affect immune response parameters. The aim of the study was to identify common genotypes of epidemic clones of Campylobacter pathogens and to investigate characteristics of the immune response and severity of the disease. Materials and methods. The study included 203 patients aged from 1 month to 17 years with campylobacteriosis who underwent treatment at the clinic of the Federal State Budgetary Institution "DNKCIB FMBA" in 2019–2021. The diagnosis was confirmed using polymerase chain reaction method. Patient samples were also analyzed using culture-based methods. Total DNA was extracted using the QIAamp DNA Mini Kit. Genetic determinants encoding virulence factors and MLST typing were performed using the ResFinder program. The immune status of patients was assessed on days 1 and 7 of the illness. Immunological investigation included measurement of serum immunoglobulin concentrations (IgA, IgM, IgG), C-reactive protein, and cytokines (IL-1β, IL-1, IL-2, IL-4, IL-5, IL-6, IL- 7, IL-8, IL-10, TNF-α, and IFN-γ). Results. When analyzing the frequency of detection of Campylobacter sequence types in children with clinical intestinal infections, it was found that the profile of isolated isolates is most similar to those from countries of North America (USA and Canada), Northern Europe (Great Britain, Holland ) and Scandinavia (Denmark, Sweden, Finland). Identification of a pathogen with the flgE+, cdtA+, cdtC+ genotype was accompanied by a statistically significant increase in the level of IL-8 and a decrease in the content of IgA in the peripheral blood serum, which reflected the low efficiency of the immune response during infection with Campylobacter and predetermined the severe course of the infectious process during the disease.
- 16 July 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (3) , 315-326
Open AccessCampylobacteriosis: genotypic characteristics of the pathogen and immunological status of patients
Introduction. Campylobacteriosis is among the leading causes of acute gastrointestinal infections. The severity of campylobacteriosis and the development of long-term complications may be influenced by the genotype of the pathogen, whose biological properties can affect immune response parameters. The aim of the study was to identify common genotypes of epidemic clones of Campylobacter pathogens and to investigate characteristics of the immune response and severity of the disease. Materials and methods. The study included 203 patients aged from 1 month to 17 years with campylobacteriosis who underwent treatment at the clinic of the Federal State Budgetary Institution "DNKCIB FMBA" in 2019–2021. The diagnosis was confirmed using polymerase chain reaction method. Patient samples were also analyzed using culture-based methods. Total DNA was extracted using the QIAamp DNA Mini Kit. Genetic determinants encoding virulence factors and MLST typing were performed using the ResFinder program. The immune status of patients was assessed on days 1 and 7 of the illness. Immunological investigation included measurement of serum immunoglobulin concentrations (IgA, IgM, IgG), C-reactive protein, and cytokines (IL-1β, IL-1, IL-2, IL-4, IL-5, IL-6, IL- 7, IL-8, IL-10, TNF-α, and IFN-γ). Results. When analyzing the frequency of detection of Campylobacter sequence types in children with clinical intestinal infections, it was found that the profile of isolated isolates is most similar to those from countries of North America (USA and Canada), Northern Europe (Great Britain, Holland ) and Scandinavia (Denmark, Sweden, Finland). Identification of a pathogen with the flgE+, cdtA+, cdtC+ genotype was accompanied by a statistically significant increase in the level of IL-8 and a decrease in the content of IgA in the peripheral blood serum, which reflected the low efficiency of the immune response during infection with Campylobacter and predetermined the severe course of the infectious process during the disease.
- Open Access
- 18 June 2024
- Published by Springer Nature in Research Square
Genomic perspective on the bacillus causing paratyphoid B fever
Paratyphoid B fever (PTB) is caused by an invasive lineage (phylogroup 1, PG1) of Salmonella enterica serotype Paratyphi B (SPB). Here, we provide a genomic overview of the population structure, geographic distribution, and evolution of SPB PG1 by analysing genomes from 568 historical and contemporary isolates, obtained globally, between 1898 and 2021. We show that this pathogen existed in the 13th century, subsequently diversifying into 11 lineages and 38 genotypes with strong phylogeographic patterns. Following its discovery in 1896, it circulated across Europe until the 1970s, after which it was mostly reimported into Europe from South America, the Middle East, South Asia, and North Africa. Antimicrobial resistance recently emerged in various genotypes of SPB PG1, mostly through mutations of the quinolone-resistance-determining regions of gyrA and gyrB. This study provides an unprecedented insight into SPB PG1 and essential genomic tools for identifying and tracking this pathogen, thereby facilitating the global genomic surveillance of PTB.
- 18 June 2024
- Published by Springer Nature in Research Square
Open AccessGenomic perspective on the bacillus causing paratyphoid B fever
Paratyphoid B fever (PTB) is caused by an invasive lineage (phylogroup 1, PG1) of Salmonella enterica serotype Paratyphi B (SPB). Here, we provide a genomic overview of the population structure, geographic distribution, and evolution of SPB PG1 by analysing genomes from 568 historical and contemporary isolates, obtained globally, between 1898 and 2021. We show that this pathogen existed in the 13th century, subsequently diversifying into 11 lineages and 38 genotypes with strong phylogeographic patterns. Following its discovery in 1896, it circulated across Europe until the 1970s, after which it was mostly reimported into Europe from South America, the Middle East, South Asia, and North Africa. Antimicrobial resistance recently emerged in various genotypes of SPB PG1, mostly through mutations of the quinolone-resistance-determining regions of gyrA and gyrB. This study provides an unprecedented insight into SPB PG1 and essential genomic tools for identifying and tracking this pathogen, thereby facilitating the global genomic surveillance of PTB.
- Open Access
- 10 May 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (2) , 208-216
Effect of the Bacillus subtilis BS20 on physiological and immune parameters in mutant mice Muc2–/–
Introduction. Inflammatory bowel disease (IBD) is a common pathology that cannot be completely cured and requires lifelong therapy. One of the promising and sparing therapeutic strategies is the use of probiotics. Unlike Lactobacillus and Bifidobacterium, which represent the basis of most classical probiotics, Bacillus spp. are spore-forming bacteria that contributes to their resistance to the acidic environment of the stomach. It has been shown that the bacteria Bacillus spp. is an effective therapeutic drug for the relief of intestinal diseases with signs of inflammation and bacterial origin. Since the main factors causing IBD are dysbiosis and inflammation, and strains of Bacillus spp. as probiotics can be potential modulators of immunity and influence the intestinal microbiome, it is necessary to search for new strains of probiotic bacteria, including representatives of Bacillus spp., which have an effect on immunity and physiological indicators in experimental models of IBD. The aim of the scientific research — to study the effect of Bacillus subtilis BS20 spores on the physiological and immune parameters of the mutant mouse line Muc2–/–. Research objectives: Investigate survival of Muc2–/– mice, weight, immune parameters (cytokines and immune cells) and amino acid composition of muscles. Materials and methods. Muc2–/– females were fed spores of Bacillus subtilis BS20 in the amount of 109 CFU for 2 months. Analysis of the amino acid composition of the femoral muscle was performed by capillary electrophoresis. The concentration of cytokines in the supernatant was measured using the Magnetic Luminex assay kit. Determination of the number of lymphocytes was performed by flow cytometry. Results. The addition of Bacillus subtilis BS20 to the diet of mice reduced mortality and body weight loss in Muc2–/– females. We found a decrease in interleukin-6 and an increase in interleukin-17 in the descending colon and an increase in B and T helper lymphocytes in the spleen. Conclusion. B. subtilis BS20 improves the general condition of Muc2–/– mutant mice, has an anti-inflammatory and immunostimulating effect, reducing the level of the cytokine interleukin-6 and increasing the percentage of B cells and T helper cells in the spleen.
- 10 May 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (2) , 208-216
Open AccessEffect of the Bacillus subtilis BS20 on physiological and immune parameters in mutant mice Muc2–/–
Introduction. Inflammatory bowel disease (IBD) is a common pathology that cannot be completely cured and requires lifelong therapy. One of the promising and sparing therapeutic strategies is the use of probiotics. Unlike Lactobacillus and Bifidobacterium, which represent the basis of most classical probiotics, Bacillus spp. are spore-forming bacteria that contributes to their resistance to the acidic environment of the stomach. It has been shown that the bacteria Bacillus spp. is an effective therapeutic drug for the relief of intestinal diseases with signs of inflammation and bacterial origin. Since the main factors causing IBD are dysbiosis and inflammation, and strains of Bacillus spp. as probiotics can be potential modulators of immunity and influence the intestinal microbiome, it is necessary to search for new strains of probiotic bacteria, including representatives of Bacillus spp., which have an effect on immunity and physiological indicators in experimental models of IBD. The aim of the scientific research — to study the effect of Bacillus subtilis BS20 spores on the physiological and immune parameters of the mutant mouse line Muc2–/–. Research objectives: Investigate survival of Muc2–/– mice, weight, immune parameters (cytokines and immune cells) and amino acid composition of muscles. Materials and methods. Muc2–/– females were fed spores of Bacillus subtilis BS20 in the amount of 109 CFU for 2 months. Analysis of the amino acid composition of the femoral muscle was performed by capillary electrophoresis. The concentration of cytokines in the supernatant was measured using the Magnetic Luminex assay kit. Determination of the number of lymphocytes was performed by flow cytometry. Results. The addition of Bacillus subtilis BS20 to the diet of mice reduced mortality and body weight loss in Muc2–/– females. We found a decrease in interleukin-6 and an increase in interleukin-17 in the descending colon and an increase in B and T helper lymphocytes in the spleen. Conclusion. B. subtilis BS20 improves the general condition of Muc2–/– mutant mice, has an anti-inflammatory and immunostimulating effect, reducing the level of the cytokine interleukin-6 and increasing the percentage of B cells and T helper cells in the spleen.